This page is part of the FHIR Specification (v4.6.0: R5 Draft Ballot). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner, RelatedPerson |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationAdministration.
Generated Narrative
instantiatesUri: http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf
status: completed
- |
* |
occurence: 15 Jan. 2015, 2:30:00 pm --> 16 Jan. 2015, 12:30:00 am
- | Text | Route | Dose | Rate[x] |
* | 1.8 mg/kg IV infusion over 30 minutes | Intravenous | 1.8 mg/kg | 20 min |
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.